肺移植接受者的高剂量塔克罗利斯:临床表现和管理
Eirini Chatzidaki1, Macé M Schuurmans1,2, Jérôme Bonzon3
1Division of Pulmonology, University Hospital Zurich, Zurich, Switzerland.
Journal of thoracic disease
|November 13, 2025
概括
塔克罗利斯过量服用在肺移植患者中很常见,通常没有明确与急性损伤的联系. 囊性纤维化患者的脆弱性增加,突出显示需要量身定制的监测和管理策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植医学 移植医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 塔克罗利木斯对于预防肺移植排斥至关重要,但具有狭窄的治疗指数,增加了过量服用的风险.
- 在肺移植患者中,太克罗利斯过量服用的临床影响尚不清楚.
- 这项研究系统地评估了肺移植接受者的塔克罗利斯过量剂量频率,严重程度和后果.
研究的目的:
- 评估肺移植患者中塔克罗利斯过量服用的频率,严重程度和临床结果.
- 为了确定与太克罗利斯过量服用相关的危险因素和并发症.
- 提出一个结构化的管理方法,对塔克罗利斯过量.
主要方法:
- 对61名肺移植接受者的回顾性单中心研究 (2022年1月 - 2023年12月).
- 塔克罗利斯过量剂量定义为最低水平≥15μg/L,分为轻度,中度或严重.
- 对临床结果,功能,并发症的分析,重点是囊性纤维化患者.
主要成果:
- 在88.5%的患者中发生过量服用塔克罗利斯,平均峰值水平为22μg/L.
- 急性损伤发生在37%的患者中,但在统计学上与过量服用无关 (P>0.99).
- 囊性纤维化患者经历了反复的过量服用; 一名患者患有后部可逆脑病综合征.
结论:
- 塔克罗利斯过量服用是肺移植后经常发生的.
- 虽然观察到AKI,但由于样本大小,无法确定与过量服用的显著关联.
- 囊性纤维化患者更容易受到伤害,强调需要个性化监测和管理.
相关概念视频
01:29Pulmonary Tuberculosis I
816
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
816
01:26Kidney Transplant II: Surgical Procedure
293
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
293
01:16Kidney Transplant III: Nursing Management
301
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
301
01:26COPD: Management Using Bronchodilators and Corticosteroids
709
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
709
01:28Pulmonary Tuberculosis V
530
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
530
01:29Therapeutic Drug Monitoring: Affecting Factors
189
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
189